iSpecimen to Participate in the Sequire Biotechnology Conference on February 2, 2023
LEXINGTON, Mass., Jan. 23, 2023 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists in need of biospecimens for medical research with a network of healthcare specimen providers, today announced that Tracy Curley, CEO of iSpecimen, will participate in the Sequire Biotechnology Conference to be held virtually on Thursday, February 2, 2023.
Ms. Curley will present at 5:00 p.m. ET. To attend, please register here.
For more information about the conference, or to schedule a one-on-one meeting with iSpecimen’s management team, please contact your appropriate Sequirerepresentative, or send an email to KCSA Strategic Communications at [email protected].
For further information, please contact:
Keynote Presentation - Fireside Chat with Dell Technologies
Keynote Presentation by ThreatLocker: Zero Trust at the Endpoint: Fighting Ransomware
Blockchain and Sustainability